Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics


Pfizer Inc. has agreed to purchase International Blood Therapeutics Inc. for $5.4 billion, in a deal that will give the large drugmaker a foothold within the remedy of sickle-cell illness.

Pfizer mentioned Monday it might pay $68.50 a share in money for International Blood Therapeutics, which has one of many few authorized therapies for sickle-cell illness. The Wall Road Journal reported Friday that the companies were in advanced talks.


Please enter your comment!
Please enter your name here

Share post:




More like this

Top 12 Most Popular Soccer Teams In the World 2023

Who's the world’s high soccer crew? There is...

24 Actress Annie Wersching Dead At 45 Following Battle With Cancer

Annie Wersching, finest identified for portraying FBI agent...

Better Education for a Healthier Gut

This examine has studied the genetic materials...

Maple Almond Buckwheat Granola – Minimalist Baker Recipes

There’s a brand new candy snack on the...